SCHEMBL25865811

SCHEMBL25865811

CC1(C)NC(C)(C)C(C)(C)C=C1c1c[nH]c2ncccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAMKK2 Q96RR4 2/20 0.45
TGFBR1 P36897 4/20 0.45
PDPK1 O15530 3/20 0.45
IKBKE Q14164 3/20 0.45
DYRK1A Q13627 3/20 0.44
BRD4 O60885 1/20 0.43
CDC7 O00311 3/20 0.43
CDK2 P24941 2/20 0.43
MAP4K4 O95819 2/20 0.43
PIM1 P11309 2/20 0.43
PRKACA P17612 2/20 0.43
GSK3B P49841 2/20 0.43
HIPK2 Q9H2X6 2/20 0.43
CLK4 Q9HAZ1 2/20 0.43
CDK9 P50750 2/20 0.43
CDK5 Q00535 2/20 0.43
ROCK2 O75116 1/20 0.43
IRAK4 Q9NWZ3 1/20 0.43
CCNT1 O60563 1/20 0.43
CCNA2 P20248 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25865813 0.79 TGFBR1 (0.45) CAMKK2TGFBR1PDPK1IKBKEDYRK1A
SCHEMBL25865826 0.77 TGFBR1 (0.44) CAMKK2TGFBR1PDPK1IKBKEDYRK1A
SCHEMBL25865806 0.76 HTR2A (0.48) CAMKK2TGFBR1PDPK1IKBKEDYRK1A
SCHEMBL25865803 0.76 HTR2A (0.53) CAMKK2TGFBR1PDPK1IKBKEDYRK1A
SCHEMBL5618155 0.74 TGFBR1 (0.71) CAMKK2TGFBR1PDPK1IKBKEDYRK1A
SCHEMBL25865829 0.73 TGFBR1 (0.44) CAMKK2TGFBR1PDPK1IKBKEDYRK1A
SCHEMBL1050911 0.72 TGFBR1 (0.60) CAMKK2TGFBR1PDPK1IKBKEDYRK1A
SCHEMBL25866085 0.72 TGFBR1 (0.44) CAMKK2TGFBR1PDPK1IKBKEDYRK1A
SCHEMBL25865809 0.72 HTR2A (0.46) CAMKK2TGFBR1PDPK1IKBKEDYRK1A
SCHEMBL25865822 0.71 HTR2A (0.51) TGFBR1PDPK1IKBKEDYRK1ABRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141225-A1 FUSED HETEROCYCLES AS 5-HT2A RECEPTOR AGONISTS ONSERO THERAPEUTICS INC. (US) 2023-07-27 WO disclosed